Browse studies

Find your next paid study

27,384 recruiting studies available now

Safety and Feasibility of Robotic Single-port (SP) Nipple Sparing Mastectomy: A Single Institution, Single Arm Pilot Trial

This is a single arm, single-center, prospective clinical trial designed to track the peri, post-operative and oncologic outcomes when utilizing the da-Vinci s…

Breast CancerHigh Risk of Breast Cancer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Deborah Farr, MDNCT05245812

Observational

Virtual Group Resilient Living Program For Patients Living With Advanced Cancer

This study is a prospective, minimal risk, non-randomized, single-arm study to determine feasibility and assess effectiveness of a Virtual Group Resilient Livi…

Advanced Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07659158

Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery (MIS)

Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients treated with minimally invasive ap…

Adult Spinal DeformityScoliosisKyphosis+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

International Spine Study Group FoundationNCT04885244

The National Center for Testing Treatments in Chronic Spinal Cord and Traumatic Brain Injury

The NCTT is a prospective, multicenter, observational research network for subjects with chronic spinal cord and/or chronic traumatic brain injury.

Spinal Cord InjuryTraumatic Brain Injury

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT02769416

Phase 1

The Effects of NTX-2001, a Novel TAAR1 Partial Agonist, on Alcohol Consumption in Adults With Alcohol Use Disorder: A Phase 1b, Randomized, Placebo-Controlled, Proof-of-Concept Study

The primary goal of this Phase 1b clinical trial is to evaluate the effects of a novel TAAR1 receptor partial agonist (NTX-2001) in adults with Alcohol Use Dis…

Alcohol Use Disorder

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Newleos Therapeutics, Inc.NCT07520292

Phase 4

A Randomized Controlled Trial: Alternative Post Procedural Analgesia With NSAIDs vs Opioids in Percutaneous Needle Tenotomy of Elbow

This study is a double-blind, randomized controlled trial comparing the effectiveness of oral acetaminophen, diclofenac, and tramadol in reducing the consumpti…

Elbow PainChronic Pain

Estimated

~$25 – $1,000

Actual pay is set by the research site.

The Cleveland ClinicNCT06373978

Phase 1

Emapalumab for the Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients

The investigators hypothesize that graft rejection after hematopoietic stem cell transplant (HSCT) is primarily driven by interferon gamma, and prophylactic in…

Hematopoietic Stem Cell TransplantationGraft Failure

Estimated

~$150 – $2,700

Actual pay is set by the research site.

Children's Hospital Medical Center, CincinnatiNCT07244419

Phase 1

A Single Arm, Open-label Phase Ib/II Study of Asciminib in HER2+ Breast Cancer Brain Metastases (ASCENdANT)

The purpose of this study is to evaluate the intracranial response rate of a combination of asciminib/trastuzumab for the treatment of patients with metastatic…

HER2+ Metastatic Breast Cancer

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Duke UniversityNCT07136428

Observational

The BrainHealth Project, a Longitudinal Study in Generally Healthy Adults

The BrainHealth Project is a longitudinal study designed to identify factors associated with brain health and cognitive performance across the lifespan. Partic…

Healthy

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Texas at DallasNCT04869111

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of V940 in Combination With Pembrolizumab and Chemotherapy as First-Line Treatment for Participants With Metastatic Squamous NSCLC (INTerpath-013)

Researchers want to know if intismeran autogene (the study treatment) given with pembrolizumab and chemotherapy can treat metastatic treatment-naive squamous n…

Squamous Non-small Cell Lung Cancer

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT07221474

Phase 2

A Phase 2, Open-Label, Multicenter Study of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)

The purpose of this study is to evaluate the effectiveness and safety of Arlocabtagene Autoleucel (BMS-986393) in participants with relapsed or refractory mult…

Multiple Myeloma

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyNCT06297226

The Rett Syndrome Global Registry

The Rett Global Registry is a fully remote, global, caregiver-reported registry to collect information about caring for a loved one with Rett syndrome. In addi…

Rett Syndrome

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Rett Syndrome Research TrustNCT04900493